Vimarsana
Biggest News Aggregation in the World

Key Genes News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Key Genes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Key Genes Today - Breaking & Trending Today

PharmaDrug Inc.: PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer - Vimarsana News

PharmaDrug Inc.: PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer

Published: February 13, 2023

Toronto, Ontario--(Newsfile Corp. - February 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development

Source: finanznachrichten.de
Related Topics:
United StatesWangy CepharanthineDaniel CohenPharmadrug IncDrug AdministrationNational Cancer Institute SurveillanceNewsfile CorpAustralia Therapeutic Goods AdministrationAustralia ResearchGenvion CorporationAmerican Cancer SocietyTherapeutic Goods AdministrationEnteric Coated Oral CepharanthineValidated Studies Reveal PotentialEnabling Esophageal CancerSairiyo TherapeuticsRegarding Forward Looking InformationCancer Stat FactsKey GenesPathways Associated With Paclitaxel ResistanceEsophageal Squamous Cell Carcinoma BasedMarcel Torney
PharmaDrug Inc.: PharmaDrug Announces Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Esophageal Cancer Study - Vimarsana News

PharmaDrug Inc.: PharmaDrug Announces Positive Findings for the Combination of Cepharanthine and Frontline Chemotherapy for IND-Enabling Esophageal Cancer Study

Published: June 16, 2022

Results show that oral cepharanthine plus paclitaxel (combination therapy) significantly reduced tumor volume and increased tumor growth inhibition at day 28, the final day of dosing compared to paclitaxel

Source: finanznachrichten.de
Related Topics:
United StatesWangy CepharanthineDaniel CohenBaillyc CepharanthineSchedulei European UnionPharmadrug IncNational Cancer Institute SurveillanceNewsfile CorpEuropean UnionEndresults ProgramAmerican Cancer SocietyEnteric Coated Oral CepharanthineDrug DesignationPharmadrug Production GmbhSairiyo TherapeuticsSuper SmartRegarding Forward Looking InformationCancer Stat FactsKey GenesPathways Associated With Paclitaxel ResistanceEsophageal Squamous Cell Carcinoma Based
Wilms Tumor: New Research Reveals Genetic Mechanisms Behind the Childhood Cancer - Vimarsana News

Wilms Tumor: New Research Reveals Genetic Mechanisms Behind the Childhood Cancer

Published: May 25, 2022

Wilms Tumor: New Research Reveals Genetic Mechanisms Behind the Childhood Cancer Pediatric cancer Wilms tumor has been responsible for several deaths of children worldwide.

Source: natureworldnews.com
Related Topics:
United StatesAnastasia Vlasova GettyAnn Roberth LurieElizabethj PerlmanNational Library Of Medicine OnAmerican Society Of Clinical OncologyChildren Oncology GroupPediatric HealthAmerican Cancer SocietyNorthwestern University Feinberg School Of MedicineGetty ImagesCell Reports MedicineNews MedicalUnited Kingdom BasedLurie ChildrenNorthwestern UniversityFeinberg SchoolOncology GroupAmerican SocietyClinical OncologyNational LibraryBrain Cancer NowLeading CauseCancer DeathsWilms Tumor